loader
Please Wait
Applying Filters...

Seqens Seqens

X

List of All Manufacturers & Suppliers for 207313 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 ACETAMINOPHEN; BUTALBITAL (1)

filter

01 DR REDDYS LABS SA (1)

filter

01 CAPSULE;ORAL (1)

filter

01 300MG;50MG (1)

filter

01 USA (1)

URL Supplier Web Content
CAPSULE;ORAL
300MG;50MG
BUTALBITAL AND ACETAMI...
USA
207313
2017-12-27
RX

Looking for CTD TGA MCC DOSSIER APPLICATION 207313

Looking for CTD TGA MCC DOSSIER APPLICATION 207313 1

19

Dr. Reddy\'s Laboratories, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

They are recognized for DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

One of their notable products is ACETAMINOPHEN; BUTALBITAL, with a corresponding application number 207313 and regulatory information .

proudly manufactured in the

approval since 2017-12-27

Dr. Reddy\'s Laboratories's BUTALBITAL AND ACETAMINOPHEN CAPSULE;ORAL, medication with 300MG;50MG of ACETAMINOPHEN; BUTALBITAL.

Post Enquiry
POST ENQUIRY